Senseonics Holdings, Inc.
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| PART I: Financial Information · | ||
|---|---|---|
| | | |
| ITEM 1: Financial Statements | | |
| | | |
| Condensed Consolidated Balance Sheets as of September 30, 2025 (Unaudited) and December 31, 2024 | | 3 |
| Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2025 and 2024 | | 4 |
| Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the three and nine months ended September 30, 2025 and 2024 | | 5 |
| Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 | | 6 |
| Notes to Unaudited Condensed Consolidated Financial Statements | | 7 |
| | | |
| ITEM 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations | | 27 |
| | | |
| ITEM 3: Quantitative and Qualitative Disclosures About Market Risk | | 38 |
| | | |
| ITEM 4: Controls and Procedures | | 39 |
| | | |
| PART II: Other Information | | 39 |
| | | |
| ITEM 1: Legal Proceedings | | 39 |
| | | |
| ITEM 1A: Risk Factors | | 40 |
| | | |
| ITEM 2: Unregistered Sales of Equity Securities and Use of Proceeds | | 46 |
| | | |
| ITEM 3: Defaults Upon Senior Securities | | 46 |
| | | |
| ITEM 4: Mine Safety Disclosures | | 46 |
| | | |
| ITEM 5: Other Information | | 47 |
| | | |
| ITEM 6: Exhibits | | 47 |
| | | |
| SIGNATURES | | 48 |
| | | |
Condensed Consolidated Balance Sheet****s
(in thousands, except share and per share data)
| | | | | | | |
|---|---|---|---|---|---|---|
| · · September 30, · · December 31, | ||||||
| · · 2025 · · 2024 | ||||||
| | | | (unaudited) | | | |
| | | | | | | |
| Assets · · · · | ||||||
| Current assets: | | | | | | |
| Cash and cash equivalents | | $34,458 | | $74,597 | ||
| Restricted cash | | | 315 | | | 315 |
| Short term investments, net | | | 76,494 | | | — |
| Accounts receivable, net | | | 4,513 | | | 1,365 |
| Accounts receivable, net - related parties | | | 2,683 | | | 4,921 |
| Inventory, net | | | 6,323 | | | 4,421 |
| Prepaid expenses and other current assets | | 6,489 | | 5,819 | ||
| Total current assets | | 131,275 | | 91,438 | ||
| | | | | | | |
| Deposits and other assets | | 4,634 | | 4,926 | ||
| Property, equipment and intangible assets, net | | 4,015 | | 4,074 | ||
| Total assets | | $139,924 | | $100,438 | ||
| Liabilities and Stockholders’ Equity (Deficit) | | | | | | |
| Current liabilities: | | | | | | |
| Accounts payable | | $5,932 | | $3,205 | ||
| Accrued expenses and other current liabilities | | 11,410 | | 13,636 | ||
| Accrued expenses and other current liabilities, related parties | | | 3,732 | | | 1,870 |
| Notes payable, current portion, net | | | — | | | 20,138 |
| Total current liabilities | | 21,074 | | 38,849 | ||
| | | | | | | |
| Long-term debt and notes payables, net | | | 35,266 | | | 34,703 |
| Non-current operating lease liabilities | | | 5,419 | | | 5,785 |
| Total liabilities | | 61,759 | | 79,337 | ||
| | | | | | | |
| Preferred stock and additional paid-in-capital, subject to possible redemption: $0.001 par value per share; 0 and 12,000 shares issued and outstanding as of September 30, 2025 and December 31, 2024 | | | — | | | 37,656 |
| Total temporary equity | | | — | | | 37,656 |
| | | | | | | |
| Commitments and contingencies | | | | | | |
| | | | | | | |
| Stockholders’ equity (deficit): | | | | | | |
| Common stock, $0.001 par value per share; 70,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 40,812,706 shares and 29,767,561 shares issued and outstanding as of September 30, 2025 and December 31, 2024 | | 41 | | 30 | ||
| Additional paid-in capital | | 1,074,200 | | 931,289 | ||
| Accumulated other comprehensive income | | | 88 | | | — |
| Accumulated deficit | | (996,164) | | (947,874) | ||
| Total stockholders’ equity (deficit) | | 78,165 | | (16,555) | ||
| Total liabilities, temporary equity and stockholders’ equity (deficit) | | $139,924 | | $100,438 | ||
Unaudited Condensed Consolidated Statements of Operations** and Comprehensive Loss**
(in thousands, except share and per share data)
| | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · Three Months Ended · · Nine Months Ended | ||||||||||||
| · · September 30, · · September 30, | ||||||||||||
| · 2025 · 2024 · 2025 · 2024 | ||||||||||||
| Revenue, net | | $4,202 | $955 | | $9,235 | | $2,322 | |||||
| Revenue, net - related parties | | | 3,893 | | | 3,308 | | | 11,766 | | | 11,853 |
| Total revenue | | | 8,095 | | | 4,263 | | | 21,001 | | | 14,175 |
| Cost of sales | | | 4,627 | | | 8,314 | | | 12,907 | | | 17,593 |
| Gross profit (loss) | | | 3,468 | | | (4,051) | | | 8,094 | | | (3,418) |
| | | | | | | | | | | | | |
| Expenses: | | | | | | | | | | | | |
| Research and development expenses | | | 7,759 | | 10,546 | | | 22,773 | | | 31,784 | |
| Selling, general and administrative expenses | | | 15,310 | | 8,250 | | | 32,733 | | 25,369 | ||
| Operating loss | | | (19,601) | | (22,847) | | | (47,412) | | (60,571) | ||
| Other income (expense), net: | | | | | | | | | | | | |
| Interest income | | | 1,236 | | | 1,010 | | | 2,884 | | | 3,584 |
| Interest expense | | | (1,171) | | | (2,133) | | | (3,745) | | | (6,266) |
| Gain on change in fair value of derivatives | | | — | | | — | | | — | | | 102 |
| Other income (expense) | | | 6 | | | (6) | | | (17) | | | 11 |
| Total other income (expense), net | | | 71 | | | (1,129) | | | (878) | | | (2,569) |
| | | | | | | | | | | | | |
| Net Loss | | | (19,530) | | | (23,976) | | | (48,290) | | | (63,140) |
| Other comprehensive income | | | | | | | | | | | | |
| Unrealized gain on marketable securities | | | 65 | | | 41 | | | 88 | | | 45 |
| Other comprehensive gain | | | 65 | | | 41 | | | 88 | | | 45 |
| Total comprehensive loss | | $(19,465) | | $(23,935) | | $(48,202) | | $(63,095) | ||||
| | | | | | | | | | | | | |
| Basic net loss per common share | | $(0.43) | | $(0.77) | | $(1.19) | | $(2.05) | ||||
| Basic weighted-average shares outstanding | | | 44,953,694 | | | 31,044,897 | | | 40,554,943 | | | 30,868,515 |
| | | | | | | | | | | | | |
| Diluted net loss per common share | | $(0.43) | | $(0.77) | | $(1.19) | | $(2.05) | ||||
| Diluted weighted-average shares outstanding | | | 44,953,694 | | | 31,044,897 | | | 40,554,943 | | | 30,868,515 |
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)
(in thousands)
| | | | | | | | | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · · · · · · · · · Accumulated · · · · · · · · · Series B | ||||||||||||||||||||
| · · Common Stock · · Paid-In · · Other · · Accumulated · · Stockholders' · · Convertible | ||||||||||||||||||||
| · Shares · Amount · Capital · Comprehensive Income (Loss) · · Deficit · · Equity (Deficit) · Preferred Stock Temporary Equity | ||||||||||||||||||||
| Three months ended September 30, 2024: | | | | | | | | | | | | | | | | | | | | |
| Balance, June 30, 2024 | | 26,763 | | $27 | | $908,980 | | $(7) | | | (908,422) | | $578 | | $37,656 | |||||
| Issuance of common stock, net of issuance costs | | 502 | | | — | | | 3,667 | | | — | | | — | | | 3,667 | | | — |
| Issued common stock for vested RSUs and ESPP purchase | | 15 | | | — | | | 76 | | | — | | | — | | | 76 | | | — |
| Issuance of warrants, net of issuance costs | | — | | | — | | | 1 | | | — | | | — | | | 1 | | | — |
| Stock-based compensation expense | | — | | | — | | | 2,432 | | | — | | | — | | | 2,432 | | | — |
| Net loss | | — | | | — | | | — | | | — | | | (23,976) | | | (23,976) | | | — |
| Other comprehensive income, net of tax | | — | | | — | | | — | | | 41 | | | — | | | 41 | | | — |
| Balance, September 30, 2024 | | 27,280 | | $27 | | $915,156 | | $34 | | $(932,398) | | $(17,181) | | $37,656 | ||||||
| | | | | | | | | | | | | | | | | | | | | |
| Nine months ended September 30, 2024: | | | | | | | | | | | | | | | | | | | | |
| Balance, December 31, 2023 | 26,518 | | $27 | | $905,038 | | $(11) | | $(869,258) | | $35,796 | | $37,656 | |||||||
| Issuance of common stock, net of issuance costs | | 538 | | | — | | | 3,667 | | | — | | | — | | | 3,667 | | | — |
| Issued common stock for vested RSUs and ESPP purchase | | 339 | | | — | | | 177 | | | — | | | — | | | 177 | | | — |
| Issuance of warrants, net of issuance costs | | — | | | — | | | 149 | | | — | | | — | | | 149 | | | — |
| Exercise of stock options and warrants | | — | | | — | | | 6 | | | — | | | — | | | 6 | | | — |
| Stock-based compensation expense | — | | | — | | | 7,160 | | | — | | | — | | | 7,160 | | | — | |
| Shares withheld related to net share settlement of equity awards | | (115) | | | — | | | (1,041) | | | — | | | — | | | (1,041) | | | — |
| Net loss | | — | | | — | | | — | | | — | | | (63,140) | | | (63,140) | | | — |
| Other comprehensive income, net of tax | — | | | — | | | — | | | 45 | | | — | | | 45 | | | — | |
| Balance, September 30, 2024 | 27,280 | | $27 | | $915,156 | $34 | | $(932,398) | | $(17,181) | | $37,656 | ||||||||
| | | | | | | | | | | | | | | | | | | | | |
| Three months ended September 30, 2025: | | | | | | | | | | | | | | | | | | | | |
| Balance, June 30, 2025 | | 40,727 | | $41 | | $1,071,290 | | $23 | | $(976,634) | | $94,720 | | $— | ||||||
| Issuance of common stock, net of issuance costs | | 68 | | | — | | | 204 | | | — | | | — | | | 204 | | | — |
| Issued common stock for vested RSUs and ESPP purchase | | 16 | | | — | | | 75 | | | — | | | — | | | 75 | | | — |
| Issuance of warrants, net of issuance costs | | — | | | — | | | (163) | | | — | | | — | | | (163) | | | — |
| Stock-based compensation expense | | — | | | — | | | 2,794 | | | — | | | — | | | 2,794 | | | — |
| Net loss | | — | | | — | | | — | | | — | | | (19,530) | | | (19,530) | | | — |
| Other comprehensive gain | | — | | | — | | | — | | | 65 | | | — | | | 65 | | | — |
| Balance, September 30, 2025 | | 40,811 | | $41 | | $1,074,200 | | $88 | | $(996,164) | | $78,165 | | $— | ||||||
| | | | | | | | | | | | | | | | | | | | | |
| Nine months ended September 30, 2025: | | | | | | | | | | | | | | | | | | | | |
| Balance, December 31, 2024 | | 29,767 | | $30 | | $931,289 | | $— | | $(947,874) | | $(16,555) | | $37,656 | ||||||
| Conversion of preferred stock | | 1,518 | | | 2 | | | 37,654 | | | — | | | — | | | 37,656 | | | (37,656) |
| Issuance of common stock, net of issuance costs | 9,255 | | | 9 | | | 98,921 | | | — | | | — | | | 98,930 | | | — | |
| Issued common stock for vested RSUs and ESPP purchase | | 378 | | | — | | | 143 | | | — | | | — | | | 143 | | | — |
| Issuance of warrants, net of issuance costs | | — | | | — | | | (163) | | | — | | | — | | | (163) | | | — |
| Stock-based compensation expense | | — | | | — | | | 7,528 | | | — | | | — | | | 7,528 | | | — |
| Shares withheld related to net share settlement of equity awards | | (107) | | | — | | | (1,172) | | | — | | | — | | | (1,172) | | | — |
| Net loss | | — | | | — | | | — | | | — | | | (48,290) | | | (48,290) | | | — |
| Other comprehensive gain | | — | | | — | | | — | | | 88 | | | — | | | 88 | | | — |
| Balance, September 30, 2025 | 40,811 | | $41 | | $1,074,200 | $88 | | $(996,164) | | $78,165 | | $— | ||||||||
| | | | | | | | | | | | | | | | | | | | | |
Senseonics Ho****ldings, Inc.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.